These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 18544440)
1. Concurrent chemotherapy and re-irradiation for locoregionally recurrent head and neck cancer. Salama JK; Vokes EE Semin Oncol; 2008 Jun; 35(3):251-61. PubMed ID: 18544440 [TBL] [Abstract][Full Text] [Related]
2. Locally recurrent, previously irradiated head and neck cancer: concurrent re-irradiation and chemotherapy, or chemotherapy alone? Wong SJ; Machtay M; Li Y J Clin Oncol; 2006 Jun; 24(17):2653-8. PubMed ID: 16763279 [TBL] [Abstract][Full Text] [Related]
3. Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer. Biagioli MC; Harvey M; Roman E; Raez LE; Wolfson AH; Mutyala S; Han HS; Markoe A Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1067-73. PubMed ID: 17967302 [TBL] [Abstract][Full Text] [Related]
4. A review on re-irradiation for recurrent and second primary head and neck cancer. Kasperts N; Slotman B; Leemans CR; Langendijk JA Oral Oncol; 2005 Mar; 41(3):225-43. PubMed ID: 15743686 [TBL] [Abstract][Full Text] [Related]
5. IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes. Sulman EP; Schwartz DL; Le TT; Ang KK; Morrison WH; Rosenthal DI; Ahamad A; Kies M; Glisson B; Weber R; Garden AS Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):399-409. PubMed ID: 18556144 [TBL] [Abstract][Full Text] [Related]
6. Re-irradiation in the management of isolated neck recurrences: current status and recommendations. Chopra S; Gupta T; Agarwal JP; Budrukkar A; Ghosh-Laskar S; Dinshaw K Radiother Oncol; 2006 Oct; 81(1):1-8. PubMed ID: 16971009 [TBL] [Abstract][Full Text] [Related]
7. Reirradiation in squamous cell head and neck cancer: recent developments and future directions. Langendijk JA; Bourhis J Curr Opin Oncol; 2007 May; 19(3):202-9. PubMed ID: 17414637 [TBL] [Abstract][Full Text] [Related]
8. Toxicity and survival outcomes of hyperfractionated split-course reirradiation and daily concurrent chemotherapy in locoregionally recurrent, previously irradiated head and neck cancers. Watkins JM; Shirai KS; Wahlquist AE; Stuart RK; Chaudhary UB; Garrett-Mayer E; Day TA; Gillespie MB; Sharma AK Head Neck; 2009 Apr; 31(4):493-502. PubMed ID: 19156831 [TBL] [Abstract][Full Text] [Related]
9. Re-irradiation of head and neck cancer-impact of total dose on outcome. Janssen S; Baumgartner M; Bremer M; Warszawski A; Stieve M; Eckardt A; Karstens JH; Meyer A Anticancer Res; 2010 Sep; 30(9):3781-6. PubMed ID: 20944169 [TBL] [Abstract][Full Text] [Related]
10. Practical considerations in the re-irradiation of recurrent and second primary head-and-neck cancer: who, why, how, and how much? Chen AM; Phillips TL; Lee NY Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1211-9. PubMed ID: 22115554 [TBL] [Abstract][Full Text] [Related]
11. Chemo re-irradiation in recurrent head and neck cancer: a single institution experience. Katodritis N; Charalampous H; Vomvas D J BUON; 2012; 17(2):397. PubMed ID: 22740226 [No Abstract] [Full Text] [Related]
12. The use of concurrent chemotherapy and radiotherapy for locoregionally advanced head and neck cancer. Vokes EE; Haraf DJ; Kies MS Semin Oncol; 2000 Aug; 27(4 Suppl 8):34-8. PubMed ID: 10952436 [TBL] [Abstract][Full Text] [Related]
13. Isolated neck recurrence after definitive radiotherapy for node-positive head and neck cancer: salvage in the dissected or undissected neck. Liauw SL; Amdur RJ; Morris CG; Werning JW; Villaret DB; Mendenhall WM Head Neck; 2007 Aug; 29(8):715-9. PubMed ID: 17274056 [TBL] [Abstract][Full Text] [Related]
14. Re-irradiation with concurrent chemotherapy in recurrent head and neck cancer: a decision analysis model based on a systematic review. Paleri V; Kelly CG Clin Otolaryngol; 2008 Aug; 33(4):331-7. PubMed ID: 18983342 [TBL] [Abstract][Full Text] [Related]
15. Reirradiation after salvage surgery and microvascular free flap reconstruction for recurrent head and neck carcinoma. Suh JD; Kim BP; Abemayor E; Sercarz JA; Nabili V; Liu JH; Juillard GJ; Blackwell KE Otolaryngol Head Neck Surg; 2008 Dec; 139(6):781-6. PubMed ID: 19041503 [TBL] [Abstract][Full Text] [Related]
16. Integration of chemotherapy in the curative treatment of locally advanced head and neck cancer. Haddad RI; Wirth L; Posner MR Expert Rev Anticancer Ther; 2003 Jun; 3(3):331-8. PubMed ID: 12820776 [TBL] [Abstract][Full Text] [Related]
17. The Wayne State University experience with adjuvant chemotherapy of head and neck cancer. al-Sarraf M; Kish JA; Ensley JF Hematol Oncol Clin North Am; 1991 Aug; 5(4):687-700. PubMed ID: 1890060 [TBL] [Abstract][Full Text] [Related]
18. The role of re-irradiation of secondary and recurrent head and neck carcinomas. Is it a potentially curative treatment? A practical approach. Cacicedo J; Navarro A; Alongi F; Gómez de Iturriaga A; Del Hoyo O; Boveda E; Casquero F; Perez JF; Bilbao P Cancer Treat Rev; 2014 Feb; 40(1):178-89. PubMed ID: 23993769 [TBL] [Abstract][Full Text] [Related]
19. ACR appropriateness criteria retreatment of recurrent head and neck cancer after prior definitive radiation expert panel on radiation oncology-head and neck cancer. McDonald MW; Lawson J; Garg MK; Quon H; Ridge JA; Saba N; Salama JK; Smith RV; Yeung AR; Yom SS; Beitler JJ; Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1292-8. PubMed ID: 21530100 [TBL] [Abstract][Full Text] [Related]
20. Reirradiation of recurrent and second primary head and neck malignancies: a comprehensive review. Kao J; Garofalo MC; Milano MT; Chmura SJ; Citron JR; Haraf DJ Cancer Treat Rev; 2003 Feb; 29(1):21-30. PubMed ID: 12633577 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]